AERA THERAPEUTICS
Live / Applied — Fourth extension granted (statement of use) (as of 18 Feb 2026)
What this means for you
Not registered yet, but its 09 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97711291
- Mark type
- Stylized text
- Filed
- 09 Dec 2022
- Published for opposition
- 30 Jan 2024
- Attorney of record
- Jessica L. Rothstein
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations and substances for the prevention and treatment of rare diseases, cancers, neurological disorders, cardiovascular disorders, inflammatory disorders, immunoregulatory disorders, metabolic disorders, autoimmune disorders, and infectious disorders
- Class 042 — Scientific and technological services: Pharmaceutical research and development
Owner
- Aera Therapeutics, Inc., Cambridge, MA, US
- Aera Therapeutics, Inc., Cambridge, MA, US
Prosecution history
- 19 Feb 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Feb 2026 — SOU EXTENSION 4 GRANTED
- 18 Feb 2026 — SOU EXTENSION 4 FILED
- 18 Feb 2026 — SOU TEAS EXTENSION RECEIVED
- 19 Sept 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Sept 2025 — SOU EXTENSION 3 GRANTED
- 18 Sept 2025 — SOU EXTENSION 3 FILED
- 18 Sept 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 04 Mar 2025 — SOU EXTENSION 2 GRANTED
- 03 Mar 2025 — SOU EXTENSION 2 FILED
- 03 Mar 2025 — SOU TEAS EXTENSION RECEIVED
- 25 Feb 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 25 Feb 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 25 Feb 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED